Is There a Connection Between Gut Microbiome Dysbiosis Occurring in COVID-19 Patients and Post-COVID-19 Symptoms?
Kai Hilpert, Ralf Mikut
Abstract
According to WHO, currently 215 countries/areas/territories report a total of more than 176 million confirmed COVID-19 cases and 3.8 million deaths (June 18, 2021). SARS-CoV-2, the causative agent of COVID-19, does not impact only the respiratory system but also the various organs in the body. It can directly or indirectly affect the pulmonary system, cardiovascular system (including heart failure), renal system (including kidney failure), hepatic system (including liver failure), gastrointestinal system, nervous system, and/or various systems, leading to shock and multi-organ failure (Zaim et al., 2020). In consequence, comorbidity in these systems leads to a higher risk for a severe disease progression.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)DysbiosisMicrobiome2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Gut microbiomeConnection (principal bundle)BiologyVirologyBetacoronavirusMetagenomicsMicrobiologyImmunologyMedicineComputational biologyBioinformaticsGeneticsDiseaseInternal medicineOutbreakInfectious disease (medical specialty)GeneStructural engineeringEngineeringLong-Term Effects of COVID-19Tryptophan and brain disordersIntensive Care Unit Cognitive Disorders